COVID Pulmonary Physiology with Martin Tobin via the EMCrit Crew emcrit.org/emcrit/covid-p… #FOAMed #FOAMcc #COVID19 #COVID19FOAM pSILI H & L Subtypes Individualized Ventilator Settings Physiologic Principles of Respiratory Management Silent Hypoxemia

#CritCare #OpenAccess bit.ly/2HPdwpU #Cerebrovascular effects of #epinephrine in #pediatric in-hospital #cardiac_arrest #FOAMed #FOAMcc #BMC #ICU #Intensive_care #Cardiopulmonary #resuscitation #spectroscopy #blood_flow Jean-Louis Vincent ISICEM

thank you Hayley Gershengorn, we are glad to participate in the 🥇editorial and talk about such an interesting topic at CHEST® Journal Critical Care!! 👏🤝Congrats George L. Anesi by the work

Let’s talk #BempedoicAcid for high-risk primary prevention in individuals with #statin intolerance   JAMA has important results for clinicians + plenty of intrigue (aka learning) for researchers. Fasten your seat belts –let’s go! 🧵1/ ja.ma/3CKRmhJ

Patient mortality after cardiorespiratory arrest remains high. We show that capnography – technology to measure CPR quality – is cost-effective, suggesting adoption could improve mortality rates & reduce burden on health systems. New in AmericanHeartJ sciencedirect.com/science/articl…

We are excited to welcome post-doctoral fellow Sérgio Decker to the Smith Center! Sérgio joins us from Hospital Moinhos, and will be working with Dhruv Kazi on health economics and cost-effectiveness research.

Happy to learn and work at the Smith Center this year! Let's make this year great one!

Happy with the editorial published in the Brazilian Medical Association journal. This short piece discusses a topic that I love: have we appropriately selected the desired outcomes for older adults? Glad to work with mentors and colleagues highlighting older adults QoL as a goal

This is the worst natural catastrophe in the history of my region. Hundreds of cities flooded, including my own. 100+ people dead. 100.000+ people displaced. Millions affected.

After years of listening and discussing with colleagues living in Brazil about your podcast, it was a pleasure to listen and meet you in person at BIDMC CVI BIDMC Smith Center grand rounds ! Thank you John Mandrola, MD for teaching us how to learn from skepticism but not nihilism

Out in JAMA Cardiology today: Environmental stressors like extreme temps, hurricanes, & wildfires associated w/ increased cardiovascular morbidity & mortality. Urgent action needed to mitigate risk, esp in vulnerable populations. #climatechange bit.ly/ClimateChangeC… BIDMC

Here we introduce for you the paradox of rare diseases therapies (using tafamidis as example): despite a smaller targeted population these high cost drugs are blockbusters for pharmaceutical companies. Trilled wt this first piece under mentorship of Dhruv Kazi BIDMC Smith Center

The Smith Center will be at #AHA24 this weekend! Check out the full schedule here: smithcenter.bidmc.org/events

Check out our cardiac rehab in MI paper led by Mohammed Essa! Post-discharge outcomes for MI–CS remain suboptimal. Rehab is a 🎯 intervention, but participation is ⬇️ and inequitable ⚖️. Next step: tackling the why and fixing the gaps! Dhruv Kazi BIDMC Smith Center

Fantastic talk by Dr Inoue Kosuke Inoue on how to use machine learning to identify individuals who derive the greatest benefit from a treatment or policy. We really need to get past focusing on “average” effects! Thank you for spending this year with us BIDMC Smith Center. Kyoto University

The proposed “Most Favored Nation Drug Pricing” (MFN-DP) plan is the most ambitious plan yet to rein in US drug spending. How did we get here? How would MFN-DP work? What are the expected short, intermediate, & long-term consequences? Here are my top 10 takeaways (so far)- 1/